Christopher Dewey - MedTech Acquisition CEO Director
MTACWDelisted Stock | USD 0.10 0.00 0.00% |
Insider
Christopher Dewey is CEO Director of MedTech Acquisition
Age | 79 |
Phone | 908 391 1288 |
MedTech Acquisition Management Team
Elected by the shareholders, the MedTech Acquisition's board of directors comprises two types of representatives: MedTech Acquisition inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MedTech. The board's role is to monitor MedTech Acquisition's management team and ensure that shareholders' interests are well served. MedTech Acquisition's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MedTech Acquisition's outside directors are responsible for providing unbiased perspectives on the board's policies.
David JD, CFO Director | ||
Christopher Dewey, CEO Director | ||
Robert JD, Chief Sec |
MedTech Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MedTech Acquisition a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Number Of Shares Shorted | 7.89 K | |||
EBITDA | (8.58 M) | |||
Net Income | 5.54 M | |||
Cash And Equivalents | 25 K | |||
Total Debt | 2.37 M | |||
Debt To Equity | 1.77 % | |||
Cash Flow From Operations | (2.74 M) | |||
Market Capitalization | 306.25 M | |||
Total Asset | 20.19 M | |||
Retained Earnings | (13.27 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in MedTech Stock
If you are still planning to invest in MedTech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MedTech Acquisition's history and understand the potential risks before investing.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |